| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name |  DisGeNet score | DisGeNet_sourceDB |
| 596 | BCL2 | C0024301 | Lymphoma, Follicular | 0.503944444300272 | BEFREE;CTD_human;GAD;LHGDN;ORPHANET |
| 596 | BCL2 | C0024299 | Lymphoma | 0.307329124648138 | BEFREE;HPO;LHGDN |
| 596 | BCL2 | C0009375 | Colonic Neoplasms | 0.289572371315507 | BEFREE;CTD_human;LHGDN;RGD |
| 596 | BCL2 | C0002395 | Alzheimer's Disease | 0.286253203502271 | BEFREE;CTD_human;GAD;RGD |
| 596 | BCL2 | C0032460 | Polycystic Ovary Syndrome | 0.281098907136852 | BEFREE;CTD_human;RGD |
| 596 | BCL2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.280274726784213 | BEFREE;CTD_human;RGD |
| 596 | BCL2 | C0020538 | Hypertensive disease | 0.280274726784213 | BEFREE;CTD_human;RGD |
| 596 | BCL2 | C0035304 | Retinal Degeneration | 0.28 | CTD_human;RGD |
| 596 | BCL2 | C0242350 | Erectile dysfunction | 0.28 | CTD_human;RGD |
| 596 | BCL2 | C0023434 | Chronic Lymphocytic Leukemia | 0.262188888815162 | BEFREE;CTD_human;GAD;LHGDN |
| 596 | BCL2 | C1458155 | Mammary Neoplasms | 0.255511140403549 | BEFREE;CTD_human;LHGDN |
| 596 | BCL2 | C0079744 | Diffuse Large B-Cell Lymphoma | 0.239979085425853 | BEFREE;CTD_human;GAD |
| 596 | BCL2 | C0024305 | Lymphoma, Non-Hodgkin | 0.232690808589735 | BEFREE;CTD_human;GAD;LHGDN |
| 596 | BCL2 | C0023467 | Leukemia, Myelocytic, Acute | 0.231550514052555 | BEFREE;CTD_human;LHGDN |
| 596 | BCL2 | C0033578 | Prostatic Neoplasms | 0.225658317540181 | BEFREE;CTD_human;GAD;LHGDN |
| 596 | BCL2 | C0001418 | Adenocarcinoma | 0.225203087261019 | BEFREE;CTD_human;LHGDN |
| 596 | BCL2 | C0009404 | Colorectal Neoplasms | 0.220778747958975 | BEFREE;CTD_human;LHGDN |
| 596 | BCL2 | C0026764 | Multiple Myeloma | 0.216758333836999 | BEFREE;CTD_human |
| 596 | BCL2 | C0014859 | Esophageal Neoplasms | 0.211169574863473 | BEFREE;CTD_human;GAD;LHGDN |
| 596 | BCL2 | C0001430 | Adenoma | 0.207142896389541 | BEFREE;CTD_human |
| 596 | BCL2 | C0035126 | Reperfusion Injury | 0.205465824929628 | CTD_human;LHGDN |
| 596 | BCL2 | C0039101 | synovial sarcoma | 0.203846174978983 | BEFREE;CTD_human |
| 596 | BCL2 | C0004352 | Autistic Disorder | 0.203831819601666 | BEFREE;CTD_human;LHGDN |
| 596 | BCL2 | C0004509 | Azoospermia | 0.202681755307501 | BEFREE;CTD_human;GAD |
| 596 | BCL2 | C0018671 | Head and Neck Neoplasms | 0.202407028523288 | CTD_human;GAD |
| 596 | BCL2 | C0004096 | Asthma | 0.201373633921065 | BEFREE;CTD_human |
| 596 | BCL2 | C0005586 | Bipolar Disorder | 0.201098907136852 | BEFREE;PSYGENET |
| 596 | BCL2 | C0015923 | Fetal Alcohol Syndrome | 0.200824180352639 | BEFREE;PSYGENET |
| 596 | BCL2 | C0036341 | Schizophrenia | 0.200549453568426 | BEFREE;PSYGENET |
| 596 | BCL2 | C0853193 | Bipolar I disorder | 0.200549453568426 | BEFREE;PSYGENET |
| 596 | BCL2 | C0345967 | Malignant mesothelioma | 0.200274726784213 | BEFREE;CTD_human |
| 596 | BCL2 | C0015672 | Fatigue | 0.200274726784213 | BEFREE;HPO |
| 596 | BCL2 | C0021364 | Male infertility | 0.200274726784213 | BEFREE;CTD_human |
| 596 | BCL2 | C0021841 | Intestinal Neoplasms | 0.200274726784213 | BEFREE;CTD_human |
| 596 | BCL2 | C0206681 | Adenocarcinoma, Clear Cell | 0.200274726784213 | BEFREE;CTD_human |
| 596 | BCL2 | C0027051 | Myocardial Infarction | 0.200274726784213 | BEFREE;CTD_human |
| 596 | BCL2 | C0334660 | Angioendotheliomatosis | 0.2 | ORPHANET |
| 596 | BCL2 | C0007621 | Neoplastic Cell Transformation | 0.2 | CTD_human |
| 596 | BCL2 | C0037579 | Soft Tissue Neoplasms | 0.2 | CTD_human |
| 596 | BCL2 | C0038002 | Splenomegaly | 0.2 | HPO |
| 596 | BCL2 | C0011581 | Depressive disorder | 0.2 | PSYGENET |
| 596 | BCL2 | C0011616 | Contact Dermatitis | 0.2 | CTD_human |
| 596 | BCL2 | C0011853 | Diabetes Mellitus, Experimental | 0.2 | CTD_human |
| 596 | BCL2 | C0520743 | Mediastinal lymphadenopathy | 0.2 | HPO |
| 596 | BCL2 | C2937358 | Cerebral Hemorrhage | 0.2 | CTD_human |
| 596 | BCL2 | C2985290 | Fetal Alcohol Spectrum Disorders | 0.2 | PSYGENET |
| 596 | BCL2 | C0015967 | Fever | 0.2 | HPO |
| 596 | BCL2 | C0016978 | gallbladder neoplasm | 0.2 | CTD_human |
| 596 | BCL2 | C0162820 | Dermatitis, Allergic Contact | 0.2 | CTD_human |
| 596 | BCL2 | C0023186 | Learning Disorders | 0.2 | CTD_human |
| 596 | BCL2 | C0206637 | Chondrosarcoma, Mesenchymal | 0.2 | CTD_human |
| 596 | BCL2 | C0023891 | Liver Cirrhosis, Alcoholic | 0.2 | CTD_human |
| 596 | BCL2 | C0023904 | Liver Neoplasms, Experimental | 0.2 | CTD_human |
| 596 | BCL2 | C1262477 | Weight decreased | 0.2 | HPO |
| 596 | BCL2 | C0025261 | Memory Disorders | 0.2 | CTD_human |
| 596 | BCL2 | C0025568 | Metaplasia | 0.2 | CTD_human |
| 596 | BCL2 | C0276535 | AIDS with Kaposi's sarcoma | 0.2 | CTD_human |
| 596 | BCL2 | C0027540 | Necrosis | 0.2 | CTD_human |
| 596 | BCL2 | C0027746 | Nerve Degeneration | 0.2 | CTD_human |
| 596 | BCL2 | C0028081 | Night sweats | 0.2 | HPO |
| 596 | BCL2 | C0029422 | Osteochondrodysplasias | 0.2 | CTD_human |
| 596 | BCL2 | C0023267 | Fibroid Tumor | 0.0964118301661998 | BEFREE;LHGDN;RGD |
| 596 | BCL2 | C0079731 | B-Cell Lymphomas | 0.0874431332334938 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0007786 | Brain Ischemia | 0.0827329124648137 | LHGDN;RGD |
| 596 | BCL2 | C0014175 | Endometriosis | 0.0819230874894917 | BEFREE;RGD |
| 596 | BCL2 | C0151744 | Myocardial Ischemia | 0.0805494535684262 | BEFREE;RGD |
| 596 | BCL2 | C0020179 | Huntington Disease | 0.0805494535684262 | BEFREE;RGD |
| 596 | BCL2 | C0021831 | Intestinal Diseases | 0.0802747267842131 | BEFREE;RGD |
| 596 | BCL2 | C0022661 | Kidney Failure, Chronic | 0.0802747267842131 | BEFREE;RGD |
| 596 | BCL2 | C0033117 | Priapism | 0.08 | RGD |
| 596 | BCL2 | C0007787 | Transient Ischemic Attack | 0.08 | RGD |
| 596 | BCL2 | C0038220 | Status Epilepticus | 0.08 | RGD |
| 596 | BCL2 | C0038358 | Gastric ulcer | 0.08 | RGD |
| 596 | BCL2 | C0038436 | Post-Traumatic Stress Disorder | 0.08 | RGD |
| 596 | BCL2 | C0376618 | Endotoxemia | 0.08 | RGD |
| 596 | BCL2 | C0011263 | Multi-infarct dementia | 0.08 | RGD |
| 596 | BCL2 | C0409959 | Osteoarthritis, Knee | 0.08 | RGD |
| 596 | BCL2 | C2607914 | Allergic rhinitis (disorder) | 0.08 | RGD |
| 596 | BCL2 | C2609414 | Acute kidney injury | 0.08 | RGD |
| 596 | BCL2 | C0015934 | Fetal Growth Retardation | 0.08 | RGD |
| 596 | BCL2 | C0017601 | Glaucoma | 0.08 | RGD |
| 596 | BCL2 | C0018801 | Heart failure | 0.08 | RGD |
| 596 | BCL2 | C0740392 | Infarction, Middle Cerebral Artery | 0.08 | RGD |
| 596 | BCL2 | C0020433 | Hyperbilirubinemia | 0.08 | RGD |
| 596 | BCL2 | C0020672 | Hypothermia, natural | 0.08 | RGD |
| 596 | BCL2 | C0752308 | Hypoxia-Ischemia, Brain | 0.08 | RGD |
| 596 | BCL2 | C0872084 | Sarcopenia | 0.08 | RGD |
| 596 | BCL2 | C0993582 | Arthritis, Experimental | 0.08 | RGD |
| 596 | BCL2 | C0023893 | Liver Cirrhosis, Experimental | 0.08 | RGD |
| 596 | BCL2 | C0242488 | Acute Lung Injury | 0.08 | RGD |
| 596 | BCL2 | C0024668 | Mammary Neoplasms, Experimental | 0.08 | RGD |
| 596 | BCL2 | C0026552 | Morphine Dependence | 0.08 | RGD |
| 596 | BCL2 | C0027055 | Myocardial Reperfusion Injury | 0.08 | RGD |
| 596 | BCL2 | C0001623 | Adrenal gland hypofunction | 0.08 | RGD |
| 596 | BCL2 | C0006142 | Malignant neoplasm of breast | 0.0569466335124351 | BEFREE;GAD |
| 596 | BCL2 | C0678222 | Breast Carcinoma | 0.0530222693531283 | BEFREE |
| 596 | BCL2 | C0023418 | leukemia | 0.044093722837093 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0025202 | melanoma | 0.0402987050154222 | BEFREE;LHGDN |
| 596 | BCL2 | C0007137 | Squamous cell carcinoma | 0.0378756423831932 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0376358 | Malignant neoplasm of prostate | 0.0342098229573777 | BEFREE;GAD |
| 596 | BCL2 | C0600139 | Prostate carcinoma | 0.0307693998318672 | BEFREE |
| 596 | BCL2 | C0019829 | Hodgkin Disease | 0.0246311872899146 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C2239176 | Liver carcinoma | 0.0219494319824135 | BEFREE;LHGDN |
| 596 | BCL2 | C0027627 | Neoplasm Metastasis | 0.0216747051982004 | BEFREE;LHGDN |
| 596 | BCL2 | C0017638 | Glioma | 0.0208505248455611 | BEFREE;LHGDN |
| 596 | BCL2 | C0596263 | Carcinogenesis | 0.0203297820317694 | BEFREE |
| 596 | BCL2 | C3714514 | Infection | 0.0191303872536963 | LHGDN |
| 596 | BCL2 | C0024141 | Lupus Erythematosus, Systemic | 0.0175153229233848 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0169675480865823 | BEFREE;GAD |
| 596 | BCL2 | C0017636 | Glioblastoma | 0.0161658141366212 | BEFREE;LHGDN |
| 596 | BCL2 | C0242379 | Malignant neoplasm of lung | 0.0144950070286644 | BEFREE;GAD |
| 596 | BCL2 | C0149925 | Small cell carcinoma of lung | 0.0139823552402336 | BEFREE;LHGDN |
| 596 | BCL2 | C0699791 | Stomach Carcinoma | 0.013736339210655 | BEFREE |
| 596 | BCL2 | C0023473 | Myeloid Leukemia, Chronic | 0.0133162319798649 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0027819 | Neuroblastoma | 0.0131868856422288 | BEFREE |
| 596 | BCL2 | C0007138 | Carcinoma, Transitional Cell | 0.0125800105645336 | BEFREE;LHGDN |
| 596 | BCL2 | C0007134 | Renal Cell Carcinoma | 0.0125432087845382 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0009402 | Colorectal Carcinoma | 0.0123627052895895 | BEFREE |
| 596 | BCL2 | C0684249 | Carcinoma of lung | 0.0123627052895895 | BEFREE |
| 596 | BCL2 | C0700095 | Central neuroblastoma | 0.0120879785053764 | BEFREE |
| 596 | BCL2 | C0235974 | Pancreatic carcinoma | 0.0115385249369502 | BEFREE |
| 596 | BCL2 | C0024121 | Lung Neoplasms | 0.0114811034276812 | BEFREE;LHGDN |
| 596 | BCL2 | C1527249 | Colorectal Cancer | 0.010989071368524 | BEFREE |
| 596 | BCL2 | C2004493 | Leukemia, B-Cell | 0.0109747159912068 | BEFREE;LHGDN |
| 596 | BCL2 | C0024623 | Malignant neoplasm of stomach | 0.0107143445843109 | BEFREE |
| 596 | BCL2 | C1306460 | Primary malignant neoplasm of lung | 0.0107143445843109 | BEFREE |
| 596 | BCL2 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0101361802612502 | BEFREE;LHGDN |
| 596 | BCL2 | C1140680 | Malignant neoplasm of ovary | 0.0100993784812548 | BEFREE;GAD |
| 596 | BCL2 | C0023470 | Myeloid Leukemia | 0.0100850231039376 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0346647 | Malignant neoplasm of pancreas | 0.0098901642316716 | BEFREE |
| 596 | BCL2 | C0598766 | Leukemogenesis | 0.0096154374474585 | BEFREE |
| 596 | BCL2 | C0699790 | Colon Carcinoma | 0.0096154374474585 | BEFREE |
| 596 | BCL2 | C0919267 | ovarian neoplasm | 0.00957237131550676 | BEFREE;LHGDN |
| 596 | BCL2 | C0178874 | Tumor Progression | 0.0093407106632454 | BEFREE |
| 596 | BCL2 | C0023449 | Acute lymphocytic leukemia | 0.0093407106632454 | BEFREE |
| 596 | BCL2 | C0030297 | Pancreatic Neoplasm | 0.00902291774708056 | BEFREE;LHGDN |
| 596 | BCL2 | C0040136 | Thyroid Neoplasm | 0.00897176058976791 | BEFREE;GAD;LHGDN |
| 596 | BCL2 | C0006413 | Burkitt Lymphoma | 0.0087912570948192 | BEFREE |
| 596 | BCL2 | C0029925 | Ovarian Carcinoma | 0.0087912570948192 | BEFREE |
| 596 | BCL2 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.00850217493328885 | BEFREE;LHGDN |
| 596 | BCL2 | C0007102 | Malignant tumor of colon | 0.008241803526393 | BEFREE |
| 596 | BCL2 | C0014170 | Endometrial Neoplasms | 0.00819873739444126 | LHGDN |
| 596 | BCL2 | C0005695 | Bladder Neoplasm | 0.00767799458064955 | BEFREE;LHGDN |
| 596 | BCL2 | C0409974 | Lupus Erythematosus | 0.0074958123540771 | BEFREE;GAD |
| 596 | BCL2 | C0024131 | Lupus Vulgaris | 0.0074958123540771 | BEFREE;GAD |
| 596 | BCL2 | C0024138 | Lupus Erythematosus, Discoid | 0.0074958123540771 | BEFREE;GAD |
| 596 | BCL2 | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0074176231737537 | BEFREE |
| 596 | BCL2 | C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 0.00712854101222335 | BEFREE;LHGDN |
| 596 | BCL2 | C0003873 | Rheumatoid Arthritis | 0.00657908744379715 | BEFREE;LHGDN |
| 596 | BCL2 | C0242596 | Neoplasm, Residual | 0.00630436065958405 | BEFREE;LHGDN |
| 596 | BCL2 | C0038356 | Stomach Neoplasms | 0.0060152784980537 | BEFREE;LHGDN |
| 596 | BCL2 | C0018213 | Graves Disease | 0.0060152784980537 | BEFREE;LHGDN |
| 596 | BCL2 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0057692624684751 | BEFREE |
| 596 | BCL2 | C0029463 | Osteosarcoma | 0.00575490709115785 | BEFREE;LHGDN |
| 596 | BCL2 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.005494535684262 | BEFREE |
| 596 | BCL2 | C0023903 | Liver neoplasms | 0.0052198089000489 | BEFREE |
| 596 | BCL2 | C0280100 | solid tumor | 0.0052198089000489 | BEFREE |
| 596 | BCL2 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.00520545352273165 | BEFREE;LHGDN |
| 596 | BCL2 | C0005684 | Malignant neoplasm of urinary bladder | 0.0049450821158358 | BEFREE |
| 596 | BCL2 | C0476089 | Endometrial Carcinoma | 0.0049450821158358 | BEFREE |
| 596 | BCL2 | C2931822 | Nasopharyngeal carcinoma | 0.0049450821158358 | BEFREE |
| 596 | BCL2 | C0699885 | Carcinoma of bladder | 0.0049450821158358 | BEFREE |
| 596 | BCL2 | C0027643 | Neoplasm Recurrence, Local | 0.004814057046576 | GAD |
| 596 | BCL2 | C0376545 | Hematologic Neoplasms | 0.0046703553316227 | BEFREE |
| 596 | BCL2 | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.00438127317009235 | BEFREE;LHGDN |
| 596 | BCL2 | C1261473 | Sarcoma | 0.00438127317009235 | BEFREE;LHGDN |
| 596 | BCL2 | C1621958 | Glioblastoma Multiforme | 0.0041209017631965 | BEFREE |
| 596 | BCL2 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0041209017631965 | BEFREE |
| 596 | BCL2 | C0555198 | Malignant Glioma | 0.0041209017631965 | BEFREE |
| 596 | BCL2 | C0206698 | Cholangiocarcinoma | 0.00410654638587925 | BEFREE;LHGDN |
| 596 | BCL2 | C0206754 | Neuroendocrine Tumors | 0.00410654638587925 | BEFREE;LHGDN |
| 596 | BCL2 | C0026769 | Multiple Sclerosis | 0.0040553892285666 | BEFREE;GAD |
| 596 | BCL2 | C0302592 | Cervix carcinoma | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C0035335 | Retinoblastoma | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C0019196 | Hepatitis C | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C1168401 | Squamous cell carcinoma of the head and neck | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C0024314 | Lymphoproliferative Disorders | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C0004364 | Autoimmune Diseases | 0.0035714481947703 | BEFREE |
| 596 | BCL2 | C0011854 | Diabetes Mellitus, Insulin-Dependent | 0.0035059356601404 | BEFREE;GAD |
| 596 | BCL2 | C0149678 | Epstein-Barr Virus Infections | 0.0032967214105572 | BEFREE |
| 596 | BCL2 | C0033860 | Psoriasis | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C0041296 | Tuberculosis | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C0019158 | Hepatitis | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C0022602 | Actinic keratosis | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C0023269 | leiomyosarcoma | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C1176475 | Ductal Carcinoma | 0.00328236603323995 | BEFREE;LHGDN |
| 596 | BCL2 | C0007847 | Malignant tumor of cervix | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C0008626 | Congenital chromosomal disease | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C0042769 | Virus Diseases | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C0585442 | Osteosarcoma of bone | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C4048328 | cervical cancer | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C1328504 | Hormone refractory prostate cancer | 0.0030219946263441 | BEFREE |
| 596 | BCL2 | C0030521 | Parathyroid Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0006145 | Breast Diseases | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0034885 | Rectal Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0036631 | Seminoma | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0042344 | Varicose Ulcer | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0497327 | Dementia | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0206658 | Smooth Muscle Tumor | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0023646 | Lichen Planus | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0024899 | Mastocytosis | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0027947 | Neutropenia | 0.00300763924902685 | BEFREE;LHGDN |
| 596 | BCL2 | C0022665 | Kidney Neoplasm | 0.0029564820917142 | BEFREE;GAD |
| 596 | BCL2 | C0345904 | Malignant neoplasm of liver | 0.002747267842131 | BEFREE |
| 596 | BCL2 | C0036690 | Septicemia | 0.002747267842131 | BEFREE |
| 596 | BCL2 | C0243026 | Sepsis | 0.002747267842131 | BEFREE |
| 596 | BCL2 | C0002736 | Amyotrophic Lateral Sclerosis | 0.002747267842131 | BEFREE |
| 596 | BCL2 | C0333641 | Atrophic | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0032019 | Pituitary Neoplasms | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C1566590 | Delayed Graft Function | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0036323 | Schistosomiasis | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0007873 | Uterine Cervical Neoplasm | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0038187 | Starvation | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C1955869 | Malformations of Cortical Development | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0042384 | Vasculitis | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C2937421 | Prostatic Hyperplasia | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0020507 | Hyperplasia | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0022116 | Ischemia | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0022593 | Keratosis | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0022603 | Seborrheic keratosis | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0206650 | Fibroadenoma | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0206720 | Squamous Cell Neoplasms | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0003130 | Anoxia | 0.00273291246481375 | LHGDN |
| 596 | BCL2 | C0007107 | Malignant neoplasm of larynx | 0.0026817553075011 | BEFREE;GAD |
| 596 | BCL2 | C0009081 | Congenital clubfoot | 0.0026817553075011 | BEFREE;GAD |
| 596 | BCL2 | C0206693 | Medullary carcinoma | 0.0026817553075011 | BEFREE;GAD |
| 596 | BCL2 | C0042133 | Uterine Fibroids | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C3539878 | Triple Negative Breast Neoplasms | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0021051 | Immunologic Deficiency Syndromes | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0023452 | Leukemia, Lymphocytic, Acute, L1 | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0023487 | Acute Promyelocytic Leukemia | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0279626 | Squamous cell carcinoma of esophagus | 0.0024725410579179 | BEFREE |
| 596 | BCL2 | C0032787 | Postoperative Complications | 0.002407028523288 | GAD |
| 596 | BCL2 | C0040715 | Chromosomal translocation | 0.002407028523288 | GAD |
| 596 | BCL2 | C0027686 | Pathologic Neovascularization | 0.002407028523288 | GAD |
| 596 | BCL2 | C0002622 | Amnesia | 0.002407028523288 | GAD |
| 596 | BCL2 | C0029295 | Oropharyngeal Neoplasms | 0.002407028523288 | GAD |
| 596 | BCL2 | C0332996 | Persistent embryonic structure | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C0036220 | Kaposi Sarcoma | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C0079740 | High Grade Lymphoma (neoplasm) | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C0079745 | Lymphoma, Large-Cell, Follicular | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C0677886 | Epithelial ovarian cancer | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C3811653 | Experimental Organism Basal Cell Carcinoma | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C1378703 | Renal carcinoma | 0.0021978142737048 | BEFREE |
| 596 | BCL2 | C1519670 | Tumor Angiogenesis | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0007103 | Malignant neoplasm of endometrium | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C1654637 | androgen independent prostate cancer | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C1883486 | Uterine Corpus Cancer | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0374997 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0079772 | T-Cell Lymphoma | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0079773 | Lymphoma, T-Cell, Cutaneous | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0019693 | HIV Infections | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0853879 | Invasive carcinoma of breast | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0024419 | Waldenstrom Macroglobulinemia | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0025149 | Medulloblastoma | 0.0019230874894917 | BEFREE |
| 596 | BCL2 | C0032927 | Precancerous Conditions | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0007112 | Adenocarcinoma of prostate | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C1709246 | Non-Neoplastic Disorder | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0008479 | Chondrosarcoma | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0376544 | Hematopoietic Neoplasms | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0524910 | Hepatitis C, Chronic | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0549473 | Thyroid carcinoma | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0085669 | Acute leukemia | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0019348 | Herpes Simplex Infections | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0740457 | Malignant neoplasm of kidney | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0153381 | Malignant neoplasm of mouth | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0153676 | Secondary malignant neoplasm of lung | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0238198 | Gastrointestinal Stromal Tumors | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C1368683 | Epithelioma | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0004114 | Astrocytoma | 0.0016483607052786 | BEFREE |
| 596 | BCL2 | C0032131 | Plasmacytoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0007785 | Cerebral Infarction | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0392514 | Hereditary hemochromatosis | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0456861 | Low grade B-cell lymphoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C3714542 | Lymphoma, Diffuse | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0205698 | Undifferentiated carcinoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0855095 | Small Lymphocytic Lymphoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0023448 | Lymphoid leukemia | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0917798 | Cerebral Ischemia | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0220633 | Uveal melanoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0024302 | Reticulosarcoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C1332225 | Aggressive Non-Hodgkin Lymphoma | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0278996 | Cancer of Head and Neck | 0.0013736339210655 | BEFREE |
| 596 | BCL2 | C0030567 | Parkinson Disease | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0004943 | Behcet Syndrome | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1704272 | Benign Prostatic Hyperplasia | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0036572 | Seizures | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1850900 | Familial primary gastric lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0346429 | Multiple malignancy | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0037286 | Skin Neoplasms | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0009324 | Ulcerative Colitis | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0041582 | Ulcer | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0456863 | High grade B-cell lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0521158 | Recurrent tumor | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C2745900 | Promyelocytic leukemia | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0524851 | Neurodegenerative Disorders | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0079747 | Low Grade Lymphoma (neoplasm) | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0677936 | Refractory cancer | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C3854222 | Human immunodeficiency virus (HIV) II infection category B1 | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0152018 | Esophageal carcinoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0751606 | Adult Acute Lymphocytic Leukemia | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0023443 | Hairy Cell Leukemia | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0206708 | Cervical Intraepithelial Neoplasia | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1274310 | Primary cutaneous B-cell lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1276146 | Cutaneous lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0025500 | Mesothelioma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1302401 | Adenoma of large intestine | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0278488 | Carcinoma breast stage IV | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0027708 | Nephroblastoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0002726 | Amyloidosis | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0279680 | Transitional cell carcinoma of bladder | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C1367654 | Marginal Zone B-Cell Lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0029423 | Cartilaginous exostosis | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0280803 | Primary central nervous system lymphoma | 0.0010989071368524 | BEFREE |
| 596 | BCL2 | C0004763 | Barrett Esophagus | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1512981 | Mammary Tumorigenesis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0333516 | Tumor necrosis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1527336 | Sjogren's Syndrome | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0006118 | Brain Neoplasms | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0007095 | Carcinoid Tumor | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0338106 | Adenocarcinoma of colon | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1719672 | Severe Sepsis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1847973 | Persistent Polyclonal B-Cell Lymphocytosis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0346957 | Disseminated Malignant Neoplasm | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0349631 | Richter's syndrome | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0349632 | Splenic Marginal Zone B-Cell Lymphoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1956346 | Coronary Artery Disease | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0010674 | Cystic Fibrosis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0041107 | Trisomy | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0424295 | Hyperactive behavior | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0042214 | Vaccinia | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0546837 | Malignant neoplasm of esophagus | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0016057 | Fibrosarcoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0595989 | Carcinoma of larynx | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0598798 | Lymphoid neoplasm | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0085281 | Addictive Behavior | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C3642345 | Luminal A Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0017658 | Glomerulonephritis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0019163 | Hepatitis B | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0151514 | Atrophic condition of skin | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0751396 | Well Differentiated Oligodendroglioma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0812413 | Malignant Pleural Mesothelioma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0850666 | helicobacter pylori infection | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0205851 | Germ cell tumor | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0854868 | Non-Hodgkin's lymphoma transformed recurrent | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0206624 | Hepatoblastoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0940937 | precancerous lesions | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0023895 | Liver diseases | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1266025 | Traditional Serrated Adenoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0024303 | Small Cell Lymphoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1292753 | Primary Effusion Lymphoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0268731 | Renal glomerular disease | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0026277 | Mixed Salivary Gland Tumor | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0026847 | Spinal Muscular Atrophy | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0026848 | Myopathy | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0278701 | Gastric Adenocarcinoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0028945 | oligodendroglioma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0280313 | Squamous cell carcinoma of oropharynx | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0029408 | Degenerative polyarthritis | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C1392224 | Centrocytic lymphoma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0030354 | Papilloma | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0302329 | Malignant lymphoma centroblastic, diffuse | 0.0008241803526393 | BEFREE |
| 596 | BCL2 | C0031511 | Pheochromocytoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1527349 | Ductal Breast Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1535510 | ADENOMAS AND ADENOCARCINOMAS | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0032463 | Polycythemia Vera | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0334590 | Anaplastic Oligodendroglioma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0007113 | Rectal Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0007114 | Malignant neoplasm of skin | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0007124 | Noninfiltrating Intraductal Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0339143 | Thyroid associated opthalmopathies | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0035078 | Kidney Failure | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0341858 | Endometriosis of uterus | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0036095 | Salivary Gland Neoplasms | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0036421 | Systemic Scleroderma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0349458 | Cervical intraepithelial neoplasia grade 1 | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1868682 | Paroxysmal kinesigenic choreoathetosis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0349566 | Squamous cell carcinoma of tongue | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0349579 | Atypical Endometrial Hyperplasia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0009447 | Common Variable Immunodeficiency | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0010054 | Coronary Arteriosclerosis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0039743 | Thanatophoric Dysplasia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0010068 | Coronary heart disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0010346 | Crohn Disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0010403 | Cryoglobulinemia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0040100 | Thymoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C2062416 | Sindbis virus infection | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C2145472 | Urothelial Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0011849 | Diabetes Mellitus | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C2349952 | Oropharyngeal Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0475801 | Leukemia, Prolymphocytic, B-Cell | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C2698750 | Pediatric Follicular Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0013080 | Down Syndrome | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0494165 | Secondary malignant neoplasm of liver | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0043116 | HMN (Hereditary Motor Neuropathy) Proximal Type I | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0521530 | Lung consolidation | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0014544 | Epilepsy | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0079746 | Immunoblastic Large-Cell Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C2936664 | Acquired Hypogammaglobulinemia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0079748 | Precursor cell lymphoblastic lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0085084 | Motor Neuron Disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C3539781 | Progressive cGVHD | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0085648 | Synovial Cyst | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0085695 | Chronic gastritis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0677898 | invasive cancer | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0017661 | IGA Glomerulonephritis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0677932 | Progressive Neoplastic Disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0678213 | Complete hydatidiform mole | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0019159 | Hepatitis A | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0694571 | extranodal lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0019189 | Hepatitis, Chronic | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0019340 | herpes | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C3888194 | MIXED LINEAGE LEUKEMIA | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0740391 | Middle Cerebral Artery Occlusion | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0151779 | Cutaneous Melanoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0020217 | Hydatidiform Mole | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C4024896 | Motor neuron atrophy | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0746102 | Chronic lung disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0152096 | Complete trisomy 18 syndrome | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0747845 | early pregnancy | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0020456 | Hyperglycemia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0153382 | Malignant neoplasm of oropharynx | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0020981 | Angioimmunoblastic Lymphadenopathy | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0153392 | Malignant neoplasm of nasopharynx | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0021345 | Infectious Mononucleosis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0153690 | Secondary malignant neoplasm of bone | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0021367 | Mammary Ductal Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0162309 | Adrenoleukodystrophy | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0021400 | Influenza | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0162566 | Porphyria Cutanea Tarda | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0850572 | Adenomatous polyp of colon | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0022548 | Keloid | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0851140 | Carcinoma in situ of uterine cervix | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0022658 | Kidney Diseases | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0022660 | Kidney Failure, Acute | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0206659 | Embryonal Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0023440 | Acute Erythroblastic Leukemia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0206718 | Ganglioneuroblastoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0948089 | Acute Coronary Syndrome | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0023492 | Leukemia, T-Cell | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0023531 | Leukoplakia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0220620 | Gastrointestinal Carcinoid Tumor | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1136084 | Plasma cell dyscrasia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0220668 | Congenital contractural arachnodactyly | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1153706 | Endometrial adenocarcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0221013 | Mastocytosis, Systemic | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1168327 | High-Grade Prostatic Intraepithelial Neoplasia | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0024115 | Lung diseases | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1258666 | Myxoid cyst | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0024117 | Chronic Obstructive Airway Disease | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1264606 | Persistent infection | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0238301 | Cancer of Nasopharynx | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0238463 | Papillary thyroid carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0262584 | Carcinoma, Small Cell | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1290375 | Mesothelioma (malignant, clinical disorder) (disorder) | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0025286 | Meningioma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0268060 | Juvenile hemochromatosis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1302547 | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0001175 | Acquired Immunodeficiency Syndrome | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1333177 | Lymphoproliferative Disorder of the Skin | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1333295 | Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1333296 | Activated B-Cell-Like Diffuse Large B-Cell Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1334170 | indolent lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0027962 | Melanocytic nevus | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1336076 | Sporadic Breast Carcinoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0002893 | Refractory anemias | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0028880 | Odontogenic Tumors | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1336745 | Thymic Lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0003850 | Arteriosclerosis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C1368771 | Burkitt-like lymphoma | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0003864 | Arthritis | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0281361 | Adenocarcinoma of pancreas | 0.0005494535684262 | BEFREE |
| 596 | BCL2 | C0004565 | Melanoma, B16 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0030552 | Paresis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1511566 | Cutaneous B-Cell Non-Hodgkin Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0004623 | Bacterial Infections | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333291 | Bleeding ulcer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1512431 | High Grade B-Cell Non-Hodgkin's Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0030581 | Parotid Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333307 | Superficial ulcer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0004779 | Basal Cell Nevus Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0030805 | Bullous pemphigoid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1516061 | Astler-Coller B1 Rectal Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0030920 | Peptic Ulcer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1519346 | Skin Carcinogenesis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0031117 | Peripheral Neuropathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333693 | Triploidy syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0031154 | Peritonitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333873 | Squamous intraepithelial lesion | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1519689 | Tumor Promotion | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333983 | Hyperplastic Polyp | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0005699 | Blast Phase | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0333997 | Lymphoid hyperplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0006012 | Borderline Personality Disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334163 | Fibrous bands | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0006079 | Bowen's Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0032226 | Pleural Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334245 | Intraepithelial Squamous Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1527383 | Morphea | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0032285 | Pneumonia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334247 | Squamous cell carcinoma, keratinizing | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1527390 | Neoplasms, Intracranial | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334299 | Carcinoid tumor no ICD-O subtype | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334505 | Synovial sarcoma, spindle cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0006287 | Bronchopulmonary Dysplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334520 | Teratoma, Malignant | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1561643 | Chronic Kidney Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334529 | Hydatidiform Mole, Partial | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1565489 | Renal Insufficiency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334579 | Anaplastic astrocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0033036 | Atrial Premature Complexes | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334580 | Protoplasmic astrocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334582 | Fibrillary Astrocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1623038 | Cirrhosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007104 | Female Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0033377 | Ptosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1629504 | Atypical Burkitt's lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0033575 | Prostatic Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1636149 | Macular dystrophy, corneal type 1 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0334664 | Mast Cell Neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1658953 | tumor vasculature | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0033999 | Pterygium | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0034063 | Pulmonary Edema | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0338656 | Impaired cognition | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1707444 | Columnar Cell Change of the Breast | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007121 | Bronchogenic Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0034494 | Rabies (disorder) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0339115 | Sebaceous adenocarcinoma of eyelid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1707446 | Columnar Cell Hyperplasia of the Breast | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1708350 | Hereditary Leiomyomatosis and Renal Cell Cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007129 | Merkel cell carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0339505 | Venous retinal branch occlusion | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1708604 | Keratocystic Odontogenic Tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007130 | Mucinous Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0339527 | Leber Congenital Amaurosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0340766 | Venous hypertension | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1709656 | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007133 | Carcinoma, Papillary | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0035309 | Retinal Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0340970 | Congenital neutropenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0035334 | Retinitis Pigmentosa | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0341038 | Jaw Keratocyst | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1762616 | Meningioma, benign, no ICD-O subtype | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0341439 | Chronic liver disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1834582 | MYELOPROLIFERATIVE SYNDROME, TRANSIENT | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0035412 | Rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1837218 | Cleft palate, isolated | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007570 | Celiac Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0342793 | Malonic aciduria | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1839839 | MAJOR AFFECTIVE DISORDER 2 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0343208 | Essential mixed cryoglobulinemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1841972 | Glucocorticoid Receptor Deficiency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007682 | CNS disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0343641 | Human papilloma virus infection | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1847319 | PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0344191 | Cerebellar decompression injury | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0036420 | Localized scleroderma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0345905 | Intrahepatic Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1848296 | DOSAGE-SENSITIVE SEX REVERSAL | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007789 | Cerebral Palsy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0346402 | Malignant neoplasm of adrenal cortex | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1853118 | Severe congenital neutropenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007867 | Cervix Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1855681 | Nephronophthisis, familial juvenile | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0007868 | Cervical dysplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0036868 | Sex Chromosome Aberrations | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1855900 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0036920 | Sezary Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1857276 | Trichohepatoenteric Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0008149 | Chlamydia Infections | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0037274 | Dermatologic disorders | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1861305 | TARSAL-CARPAL COALITION SYNDROME | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0008312 | Primary biliary cirrhosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0349459 | Cervical intraepithelial neoplasia grade 2 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1862382 | SVEINSSON CHORIORETINAL ATROPHY | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0008354 | Cholera | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0349529 | Gastric Carcinoid Tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1862941 | Amyotrophic Lateral Sclerosis, Sporadic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0349530 | Early gastric cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0349532 | Gastric lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0009319 | Colitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1955634 | Kaposi's sarcoma-associated herpesvirus infection | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0038454 | Cerebrovascular accident | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0349637 | Common acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1956130 | Lymphoma, Follicular, Grade 1 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0038826 | Superinfection | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1956131 | Lymphoma, Follicular, Grade 3 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0375023 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1956132 | Lymphoma, Follicular, Grade 2 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0009663 | Condylomata Acuminata | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0039590 | Testicular Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1959589 | Angioma, Cavernous | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0039984 | Thoracic Outlet Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1960397 | Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0040021 | Thromboangiitis Obliterans | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0040034 | Thrombocytopenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0396072 | Laryngeal papillomatosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1998028 | Photoreceptor degeneration | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0010709 | Cyst | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0040128 | Thyroid Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0398367 | Histiocytic Necrotizing Lymphadenitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011195 | Dejerine-Sottas Disease (disorder) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0403814 | Congenital bilateral aplasia of vas deferens | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2020284 | Stickler syndrome, type 1 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011265 | Presenile dementia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011311 | Dengue Fever | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0410207 | Tubular Aggregate Myopathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0041364 | Tumor Lysis Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2242987 | Benign Mastocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011608 | Dermatitis Herpetiformis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0432409 | Trisomy 11 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2267231 | Chronic idiopathic neutropenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011615 | Dermatitis, Atopic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0041696 | Unipolar Depression | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0456483 | Simple Endometrial Hyperplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2316810 | Chronic kidney disease stage 5 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0042065 | Genitourinary Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2347126 | Microscopic Polyarteritis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0042170 | Uveomeningoencephalitic Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0474808 | Follicular neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0474809 | Endometrioid tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2698259 | Monoclonal B-Cell Lymphocytosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0011881 | Diabetic Nephropathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0042721 | Viral hepatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2711227 | Steatohepatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0013264 | Muscular Dystrophy, Duchenne | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2717836 | Steroid Sulfatase Deficiency Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0013336 | Dwarfism | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0042900 | Vitiligo | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2717961 | Thrombotic Microangiopathies | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0013595 | Eczema | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0014038 | Encephalitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0079218 | Fibromatosis, Aggressive | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2748503 | Corneal Dystrophy, Subepithelial Mucinous | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0079588 | Ichthyosis, X-Linked | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2853945 | Non-follicular lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0014173 | Endometrial Hyperplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2931189 | Neural crest tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0543697 | Mixed cryoglobulinemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2931618 | Gestational trophoblastic disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0014457 | Eosinophilia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0546817 | Fluid overload | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2931852 | Clear-cell metastatic renal cell carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0014556 | Epilepsy, Temporal Lobe | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2936349 | Plaque, Amyloid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0549523 | Oropharynx (excludes nasopharynx) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0079758 | Lymphoma, Mixed-Cell, Follicular | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0553723 | Squamous cell carcinoma of skin | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0079770 | Lymphoma, Small Noncleaved-Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0558353 | Tongue Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2986665 | Early-Stage Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0580174 | Portal hypertensive gastropathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C2987516 | Cervix Intraepithelial Neoplasia Grade 3 AJCC v7 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0079774 | Peripheral T-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3146257 | Stage II Colon Cancer AJCC v7 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0016412 | Folic Acid Deficiency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0080032 | Pleural Effusion, Malignant | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3146271 | Stage III Breast Cancer AJCC v7 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0016629 | Fowlpox | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085077 | Sweet Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3203102 | Idiopathic pulmonary arterial hypertension | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3241937 | Nonalcoholic Steatohepatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0017097 | Gardner Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085090 | Lymphoma, AIDS-Related | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3272525 | Monomorphic CD56+ Intestinal T-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0017152 | Gastritis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085110 | Severe Combined Immunodeficiency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0598935 | Tumor Initiation | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3272820 | Ulcerative Colitis-Associated Colorectal Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0017154 | Gastritis, Atrophic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085136 | Central Nervous System Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0600039 | Urinary outflow obstruction | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0017547 | Gigantism | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3536714 | Renal dysplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085390 | Li-Fraumeni Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0677483 | carcinoma of the testis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0677607 | Hashimoto Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3642346 | Luminal B Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0085702 | Monocytosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3658266 | Prostatic Cancer, Castration-Resistant | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0018206 | granulosa cell tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0086025 | Codependency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3665593 | Melanocytic nevus of skin | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0086181 | Intravenous Drug Abuse | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0086533 | Leiomyoma, Epithelioid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0086543 | Cataract | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3714581 | Multicystic Dysplastic Kidney | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0018939 | Hematological Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0086981 | Sicca Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0685938 | Malignant neoplasm of gastrointestinal tract | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3714948 | PACHYONYCHIA CONGENITA 3 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0087169 | Withdrawal Symptoms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3809250 | ESTROGEN RESISTANCE | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0687120 | Nephronophthisis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0149782 | Squamous cell carcinoma of lung | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3854173 | Pre-renal acute kidney injury | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0149978 | Adenocarcinoma of rectum | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3887461 | Head and Neck Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3887486 | Interstitial lung fibrosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0699893 | Skin carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0019621 | Histiocytosis, Langerhans-Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0151546 | Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3887524 | Skin Erosion | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0151740 | Intracranial Hypertension | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0730328 | Central Serous Chorioretinopathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C3898709 | Intestinal Type Sinonasal Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C4021107 | Non-obstructive azoospermia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0151786 | Muscle Weakness | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0020258 | Hydrocephalus, Normal Pressure | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0151814 | Coronary Occlusion | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0744310 | gastritis h pylori | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0744483 | growth hormone treatment | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C4054043 | Secondary Peripheral Chondrosarcoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0020443 | Hypercholesterolemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C4054122 | Rat Adrenal Gland Pheochromocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0020455 | Hypergammaglobulinemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C4054726 | Infant Leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0152171 | Idiopathic pulmonary hypertension | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0748168 | Pulmonary Pathology | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C4082937 | Necrotizing enterocolitis in fetus OR newborn | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0152256 | Disuse osteoporosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0152268 | Hodgkin's disease, nodular sclerosis (clinical) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0751569 | Genitourinary Cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0020676 | Hypothyroidism | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0751688 | Malignant Squamous Cell Neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0153452 | Malignant neoplasm of gallbladder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0751955 | Brain Infarction | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0021294 | Infant, Premature | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0752347 | Lewy Body Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0155626 | Acute myocardial infarction | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0795878 | Monosomy 22 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0796126 | AICARDI-GOUTIERES SYNDROME 1 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0021390 | Inflammatory Bowel Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0162557 | Liver Failure, Acute | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0813147 | Stage I Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0162670 | Mitochondrial Myopathies | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0162810 | Cicatrix, Hypertrophic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0022346 | Icterus | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0162830 | Dermatitis, Phototoxic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0851135 | In situ cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0178664 | Glomerulosclerosis (disorder) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0205642 | Adenocarcinoma, Oxyphilic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0854778 | Resectable Pancreatic Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0205748 | Dysplastic Nevus | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0854866 | Non-Hodgkin's lymphoma recurrent | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206067 | Focal Epithelial Hyperplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0854917 | Rhabdoid Tumor of the Kidney | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0022680 | Polycystic Kidney Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0855139 | Monocytoid B-cell lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0855146 | Precursor B-lymphoblastic lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023223 | Leg Ulcer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0858252 | breast adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0862030 | B Lymphoblastic Leukemia/Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0862506 | Borderline ovarian tumour | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206677 | Adenomatous Polyps | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0870082 | Hyperkeratosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206687 | Carcinoma, Endometrioid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0877015 | Pelvic Organ Prolapse | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0878500 | Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206695 | Carcinoma, Neuroendocrine | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0887833 | Carcinoma, Pancreatic Ductal | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206696 | Carcinoma, Signet Ring Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023461 | Leukemia, Mast-Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206701 | Cystadenocarcinoma, Serous | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0920646 | Renal ischaemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0936223 | Metastatic Prostate Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206717 | Olfactory Neuroblastoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206719 | Central Neurocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0948380 | Colorectal cancer metastatic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0948853 | euthymia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0206721 | Inverted Papilloma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0949541 | Hurthle Cell Tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023524 | Leukoencephalopathy, Progressive Multifocal | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0220597 | Adult Hodgkin Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1096063 | Drug Resistant Epilepsy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023530 | Leukopenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0220615 | Adult Acute Myeloblastic Leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1112746 | liver lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1134719 | Invasive Ductal Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023532 | Leukoplakia, Oral | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0220621 | pediatric acute myeloblastic leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1135868 | Gestational Trophoblastic Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1136033 | Cutaneous Mastocytosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023827 | liposarcoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0023890 | Liver Cirrhosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0220648 | Renal Pelvis and Ureter Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0221228 | Comedone | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1168328 | Low Grade Prostatic Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0221269 | Pseudolymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0233514 | Abnormal behavior | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0235618 | Proliferative glomerulonephritis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0235653 | Malignant neoplasm of female breast | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0235782 | Gallbladder Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1264190 | Follicular non-Hodgkin's lymphoma, large cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0238190 | Inclusion Body Myositis (disorder) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1265996 | Large cell neuroendocrine carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0024143 | Lupus Nephritis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266002 | Non-small cell carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0024232 | Lymphatic Metastasis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0238339 | Hereditary pancreatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266005 | Basaloid squamous cell carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0238461 | Anaplastic thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0238462 | Medullary carcinoma of thyroid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266029 | Enterochromaffin-like cell carcinoid | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266050 | Poorly Differentiated Thyroid Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0239946 | Fibrosis, Liver | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266091 | Thymoma, type A | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0024304 | Lymphoma, Mixed-Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0240803 | Primary cerebral lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266095 | Thymoma, type B2 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266119 | Solitary fibrous tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266123 | Angiomyofibroblastoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1266184 | Atypical teratoid/rhabdoid tumor | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0024530 | Malaria | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1269683 | Major Depressive Disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1270972 | Mild cognitive disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0242852 | Proliferative vitreoretinopathy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0024897 | Mastocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1275278 | Extraskeletal Myxoid Chondrosarcoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0259770 | Epithelial inclusion cyst | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1279296 | Chronic leukemia (category) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0263630 | Hypertrophic disorder of skin, unspecified | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1282496 | Metastasis from malignant tumor of prostate | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0265264 | Holt-Oram syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0266999 | Vesicular Stomatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0025295 | Meningitis, Pneumococcal | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1292754 | Mediastinal (Thymic) Large B-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0268398 | Familial lichen amyloidosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1292758 | Precursor T-cell lymphoblastic lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0025517 | Metabolic Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0268647 | Lysinuric Protein Intolerance | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1292778 | Chronic myeloproliferative disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0026010 | Microphthalmos | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0270549 | Generalized Anxiety Disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1301034 | Pancreatic intraepithelial neoplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0270814 | Spastic syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1301362 | Lymphoma, Primary Cutaneous Anaplastic Large Cell | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0270952 | Muscular Dystrophy, Oculopharyngeal | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0271055 | Rhegmatogenous retinal detachment | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0272173 | Myelokathexis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0272285 | Heparin-induced thrombocytopenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1306759 | Eosinophilic disorder | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0276199 | Canarypox (disorder) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1318518 | Infantile malignant osteopetrosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0000768 | Congenital Abnormality | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278479 | Stage II Colon Cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1328840 | Autoimmune Lymphoproliferative Syndrome | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001080 | Achondroplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027121 | Myositis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278487 | Stage III Breast Cancer AJCC v6 | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1332078 | Anaplastic large cell lymphoma, ALK negative | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027439 | Nasopharyngeal Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001339 | Acute pancreatitis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027533 | Neck Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278504 | Non-small cell lung cancer stage I | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1332271 | Perianal Squamous Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278601 | Inflammatory Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1332629 | Breast Fibrocystic Change, Proliferative Type | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278620 | refractory plasma cell neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1333171 | Primary Cutaneous Follicle Center Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001486 | Adenovirus Infections | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1333172 | Cutaneous Follicular Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027662 | Multiple Endocrine Neoplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278725 | Small cell lung cancer limited stage | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001624 | Adrenal Gland Neoplasms | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278791 | Chronic lymphocytic leukaemia refractory | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001787 | Osteoporosis, Age-Related | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278838 | Prostate cancer recurrent | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0001857 | AIDS related complex | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0278883 | Metastatic melanoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1333782 | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0002170 | Alopecia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027868 | Neuromuscular Diseases | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1334177 | Infiltrating Cervical Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0279583 | T-cell childhood acute lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1334274 | Invasive Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0027960 | Nevus | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1334956 | Neuroepithelial, Perineurial, and Schwann Cell Neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0002793 | Anaplasia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0279672 | Cervical Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1335377 | Periampullary Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0002871 | Anemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0028259 | Nodule | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1335701 | Recurrent Follicular Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0002874 | Aplastic Anemia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280028 | Refractory anemia with excess blasts in transformation (clinical) | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1336527 | Carcinoma of urinary bladder, superficial | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0002894 | Refractory anaemia with excess blasts | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0029124 | Optic Atrophy | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280255 | stage, endometrial cancer | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1336753 | Thyroid Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0003469 | Anxiety Disorders | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0003504 | Aortic Valve Insufficiency | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0029401 | Osteitis Deformans | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280324 | Laryngeal Squamous Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1368019 | Paget Disease | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280631 | Leiomyosarcoma of uterus | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0003855 | Arteriovenous fistula | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280783 | Juvenile Pilocytic Astrocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0280785 | Diffuse Astrocytoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1370932 | carcinoma of the renal pelvis and ureter | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0029453 | Osteopenia | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0029454 | Osteopetrosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1384583 | Congenital absence of germinal epithelium of testes | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0281658 | Intraocular Lymphoma | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0004153 | Atherosclerosis | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0282606 | Myomatous neoplasm | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1395512 | Placental dysfunction | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C0282612 | Prostatic Intraepithelial Neoplasias | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1449563 | Cardiomyopathy, Familial Idiopathic | 0.0002747267842131 | BEFREE |
| 596 | BCL2 | C1456781 | Benign melanocytic nevus | 0.0002747267842131 | BEFREE |